Alkem Laboratories Limited

The Alkem Laboratories Limited was established in year 1973, headquartered in Mumbai. It is having 21 manufacturing facilities at multiple locations in India and the United States of America. Its upper crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA UK, SAHPRA South Africa, TGA Australia, ANVISA Brazil, WHO, TPD Health Canada, PPB Kenya, NDA Uganda, MOH Sudan, INVIMA Colombia, TFDA Tanzania, Zimbabwe, BfArM Germany and Other Africa, Asian & CIS Countries. The company has completed its Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited on 23 December 2015.